Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | CTSS | P25774 | 2/20 | 0.50 |
| ▸ | CTSK | P43235 | 2/20 | 0.50 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.50 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.50 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.50 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.50 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.50 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.50 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7160698 | 0.89 | CTSK (0.64) | CYP2C19CTSSCTSKPSEN1PSEN2 | |
| SCHEMBL7973743 | 0.87 | CYP2C19 (0.61) | CYP2C19LMNAALDH1A1CYP2D6SRC | |
| SCHEMBL2120942 | 0.86 | CTSS (0.49) | CYP2C19CTSSCTSKKCNQ2LMNA | |
| SCHEMBL27659178 | 0.86 | CYP2C19 (0.52) | CYP2C19LMNAPTGS1CYP2D6SRC | |
| SCHEMBL2872818 | 0.86 | APAF1 (0.53) | CYP2C19LMNAALDH1A1PTGS1PTGS2 | |
| SCHEMBL4039064 | 0.84 | CTSK (0.67) | CTSSCTSKPSEN1PSEN2APH1B | |
| SCHEMBL4309572 | 0.84 | CTSK (0.67) | CTSSCTSKPSEN1PSEN2APH1B | |
| SCHEMBL4310706 | 0.84 | CTSK (0.67) | CTSSCTSKPSEN1PSEN2APH1B | |
| SCHEMBL7381199 | 0.84 | PTGS1 (0.54) | CTSSCTSKPTGS1CTSLCYP2D6 | |
| SCHEMBL8583905 | 0.84 | CYP2C19 (0.50) | CYP2C19LMNAPTGS1PTGS2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2047908-B1 | METHOD FOR PREPARING A HYDROGENATION CATALYST COMPOSITION AND USE THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2017-02-22 | — | — | EP | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| EP-1948773-A1 | FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS | Henkel AG & Co. KGaA (DE) | 2008-07-30 | — | — | EP | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| WO-2007054177-A1 | FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS | HENKEL AG & CO. KGAA (DE) | 2007-05-18 | — | — | WO | claimed |
| CN-1625411-A | Combination of a NSAID and a PDE-4 inhibitor | ALTANA PHARMA AG (DE) | 2005-06-08 | — | — | CN | claimed |
| CN-1354740-A | Pharmaceutical compounds | NICOX SA (FR) | 2002-06-19 | — | — | CN | claimed |
| CN-115803309-B | Odorous compounds and process for their preparation | 丝趣科尔卡有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-107847958-B | Switchable digital scent generation and release and vapor and liquid delivery methods and systems | 加利福尼亚大学董事会 | 2024-01-16 | — | — | CN | disclosed |
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | NATIONAL INSTITUTES OF HEALTH | 2023-05-11 | — | — | US | disclosed |
| CN-114795402-A | Scoring balloon with translating score line | 巴德股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| EP-3914685-A1 | MULTI-COMPONENT CLEANING SYSTEM | Henkel AG & Co. KGaA (DE) | 2021-12-01 | — | — | EP | disclosed |
| EP-2145042-B2 | TEXTILE SCENTING | HENKEL AG & CO KGAA (DE) | 2021-10-06 | — | — | EP | disclosed |
| EP-0693254-A1 | Gel formulations containing insecticides for vaporizer systems | BAYER AG (DE) | 1996-01-24 | — | — | EP | disclosed |
| EP-0675103-A2 | Derivatives of essential fatty acids and nonsteroidal antiinflammatory drugs | SCOTIA HOLDINGS PLC (GB) | 1995-10-04 | — | — | EP | disclosed |
| US-5281617-A | Enzyme inhibitor | CORTECH, INC. (US) | 1994-01-25 | — | — | US | disclosed |
| EP-0386243-A1 | PLATINUM (II) COMPLEXES | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1990-09-12 | — | — | EP | disclosed |
| EP-0340289-A1 | LIQUID IBUPROFEN COMPOSITIONS AND METHODS OF MAKING THEM | ORATECH PHARMACEUTICAL DEVELOPMENT CORPORATION (US) | 1989-11-08 | — | — | EP | disclosed |
| US-4264582-A | IN CONJUNCTION WITH A PHOSPHONATE COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1981-04-28 | — | — | US | disclosed |
| US-4186270-A | CHLOROMETHYLATION, CONVERSION TO NITRILE, METHYLATION OR ETHYLATION, HYDROLYSIS | THE DOW CHEMICAL COMPANY (US) | 1980-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | HAVCR2, CD44, ENGASE | CYP2C19 4716/4885CTSS 406/4885CTSK 371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.